ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,208Medicare Part D Prescriptions Filled, Including Refills

Rank: 105 out of 1111

$808K Total Retail Price of All Prescriptions

Rank: 74 out of 1111

400 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 400 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 400 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

1% of this provider’s 9,815 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 491 433 1 3
LISINOPRIL 432 344 2 2
HYDROCODONE-ACETAMINOPHEN 429 321 S3 3 1
FUROSEMIDE 415 318 4 6
SIMVASTATIN 385 324 5 5
OMEPRAZOLE 380 336 6 4
POTASSIUM CHLORIDE 345 320 7 9
AMLODIPINE BESYLATE 335 297 8 7
METFORMIN HCL 261 179 9 8
ATORVASTATIN CALCIUM 218 169 10 15
CITALOPRAM HBR 198 167 11 14
METOPROLOL TARTRATE 174 130 12 12
TRAMADOL HCL 173 134 13 13
METOPROLOL SUCCINATE 164 150 14 20
GABAPENTIN 154 109 15 10
NEXIUM 143 115 16 26
NAMENDA 143 143 16 31
WARFARIN SODIUM 141 134 18 19
HYDROCHLOROTHIAZIDE 140 124 19 11
TAMSULOSIN HCL 135 106 20 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 133 80 21 23
EXELON 127 127 22 121
DIOVAN 126 125 23 51
CARVEDILOL 120 115 24 21
ADVAIR DISKUS 118 106 25 43
MELOXICAM 117 92 26 18
FLUTICASONE PROPIONATE 110 95 27 27
SPIRIVA 109 75 28 53
RANITIDINE HCL 105 78 29 29
ISOSORBIDE MONONITRATE ER 104 67 30 73
TRAZODONE HCL 100 80 31 32
POLYETHYLENE GLYCOL 3350 97 96 32 45
ALENDRONATE SODIUM 92 85 33 35
CRESTOR 89 77 34 33
PROAIR HFA 88 80 35 38
CLOPIDOGREL 78 55 36 30
ROPINIROLE HCL 78 63 36 68
LANTUS 77 61 38 46
PRAVASTATIN SODIUM 77 52 38 17
ZOLPIDEM TARTRATE 76 50 40 16
AZITHROMYCIN 75 61 41 39
PAROXETINE HCL 74 44 42 55
DONEPEZIL HCL 72 72 43 25
LYRICA 71 42 44 62
ESCITALOPRAM OXALATE 69 61 45 78
MIRTAZAPINE 68 66 46 52
ZETIA 66 38 47 109
DIGOXIN 65 53 48 47
PLAVIX 65 45 48 49
LOSARTAN POTASSIUM 63 63 50 34
GLIMEPIRIDE 63 50 50 61
LIPITOR 62 45 52 116
ALLOPURINOL 61 58 53 36
CYMBALTA 58 42 54 40
ALBUTEROL SULFATE 55 39 55 136
CIPROFLOXACIN HCL 54 47 56 58
NOVOLOG 54 37 56 104
ATENOLOL 51 42 58 22
VENLAFAXINE HCL 51 32 58 191
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 27, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.